BSX
Boston Scientific Corporation
NYSE · USHealthcareMedical - Devices
$43.77-0.59%
Price as of Jul 20, 2026
BSX profitability
Boston Scientific Corporation profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 70.4%
- EBITDA margin
- 27.5%
- EBIT margin
- 20.1%
- Net margin
- 17.2%
- Free cash flow margin
- 16.7%
Returns
- Return on equity
- 13.7%
- Return on assets
- 8.0%
- Return on invested capital
- 11.2%
- Asset turnover
- 0.47x
Cash efficiency
- Cash from operations
- $4.3B
- Cash per share
- $1.03
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.